help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2006-0224
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogunwobi, O.
Right arrow Articles by Beales, I. L. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogunwobi, O.
Right arrow Articles by Beales, I. L. P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Esophageal Cancer
Endocrinology Vol. 147, No. 9 4505-4516
Copyright © 2006 by The Endocrine Society

Leptin Stimulates Proliferation and Inhibits Apoptosis in Barrett’s Esophageal Adenocarcinoma Cells by Cyclooxygenase-2-Dependent, Prostaglandin-E2-Mediated Transactivation of the Epidermal Growth Factor Receptor and c-Jun NH2-Terminal Kinase Activation

Olorunseun Ogunwobi, Gabriel Mutungi and Ian L. P. Beales

Biomedical Research Centre (O.O., G.M., I.L.P.B.), School of Medicine, Health Policy, and Practice, University of East Anglia, Norwich NR4 7TJ, United Kingdom; and Department of Gastroenterology (I.L.P.B.), Norfolk and Norwich University Hospital, Norwich NR4 7UZ, United Kingdom

Address all correspondence and requests for reprints to: Dr. Ian Beales, School of Medicine, Health Policy, and Practice, University of East Anglia, Norwich NR4 7TJ, United Kingdom. E-mail: i.beales{at}uea.ac.uk.

Obesity is an important risk factor for esophageal adenocarcinoma (EAC), and elevated serum leptin is characteristic of obesity. We hypothesized that leptin may have biological effects in promoting esophageal adenocarcinoma and examined the effects of leptin on the OE33 Barrett’s-derived EAC line. Proliferation was assessed by dimethylthiazoldiphenyltetra-zoliumbromide and 5-bromo-2'-deoxyuridine incorporation assays and apoptosis by ELISA of intracellular nucleosomes. Intracellular signaling was examined using specific pharmacological inhibitors and direct detection of phosphorylated active kinases. Expression of the long and short leptin receptors by OE33 cells was confirmed by RT-PCR, Western blotting and immunocytochemistry. Leptin stimulated OE33 cell proliferation in a dose-dependent manner and inhibited apoptosis. These effects were dependent on cyclooxygenase (COX)-2 and replicated by adding prostaglandin E2 (PGE2). The effects of PGE2 and leptin were abolished by the EP-4 antagonist AH23848. ERK, p38 MAPK, phosphatidylinositol 3'-kinase/Akt, and Janus tyrosine kinase (JAK)-2 were activated upstream of COX-2 induction, whereas the epidermal growth factor receptor and c-Jun NH2-terminal kinase (JNK) were downstream of COX-2. The activation of ERK and Akt but not p38 MAPK was JAK2 dependent. PGE2 stimulated phosphorylation of JNK in an EGF receptor-dependent manner, and activation of the epidermal growth factor receptor required protein kinase C, src, and matrix metalloproteinase activities. We conclude that leptin stimulates cell proliferation and inhibits apoptosis in OAC cells via ERK, p38 MAPK, phosphatidylinositol 3'-kinase/Akt, and JAK2-dependent activation of COX-2 and PGE2 production. Subsequent PGE2-mediated transactivation of the epidermal growth factor receptor and JNK activation are essential to the leptin effects. These effects may contribute to the greatly increased risk of esophageal adenocarcinoma in obesity.




This article has been cited by other articles:


Home page
EndocrinologyHome page
N. Kanda and S. Watanabe
Leptin Enhances Human {beta}-Defensin-2 Production in Human Keratinocytes
Endocrinology, October 1, 2008; 149(10): 5189 - 5198.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
B J Kendall, G A Macdonald, N K Hayward, J B Prins, I Brown, N Walker, N Pandeya, A C Green, P M Webb, D C Whiteman, et al.
Leptin and the risk of Barrett's oesophagus
Gut, April 1, 2008; 57(4): 448 - 454.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
D C Whiteman, S Sadeghi, N Pandeya, B M Smithers, D C Gotley, C J Bain, P M Webb, A C Green, and for the Australian Cancer Study
Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus
Gut, February 1, 2008; 57(2): 173 - 180.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
F Francois, J Roper, A J Goodman, Z Pei, M Ghumman, M Mourad, A Z O. de Perez, G I Perez-Perez, C-H Tseng, and M J Blaser
The association of gastric leptin with oesophageal inflammation and metaplasia
Gut, January 1, 2008; 57(1): 16 - 24.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
Abstracts
Gut, April 1, 2007; 56(suppl_2): a1 - a145.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society